228 related articles for article (PubMed ID: 32766818)
1. Patterns of multimorbidity and pharmacotherapy: a total population cross-sectional study.
Forslund T; Carlsson AC; Ljunggren G; Ärnlöv J; Wachtler C
Fam Pract; 2021 Mar; 38(2):132-140. PubMed ID: 32766818
[TBL] [Abstract][Full Text] [Related]
2. Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.
Menditto E; Gimeno Miguel A; Moreno Juste A; Poblador Plou B; Aza Pascual-Salcedo M; Orlando V; González Rubio F; Prados Torres A
PLoS One; 2019; 14(2):e0210701. PubMed ID: 30726245
[TBL] [Abstract][Full Text] [Related]
3. Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care.
Stafford G; Villén N; Roso-Llorach A; Troncoso-Mariño A; Monteagudo M; Violán C
Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501805
[TBL] [Abstract][Full Text] [Related]
4. Non-random relations in drug use expressed as patterns comprising prescription and over-the-counter drugs in multimorbid elderly patients in primary care: Data of the exploratory analysis of the multicentre, observational cohort study MultiCare.
Krüger C; Schäfer I; van den Bussche H; Baehr M; Bickel H; Fuchs A; Gensichen J; Maier W; Riedel-Heller SG; König HH; Dahlhaus A; Schön G; Weyerer S; Wiese B; von Renteln-Kruse W; Langebrake C; Scherer M
Eur J Gen Pract; 2021 Dec; 27(1):119-129. PubMed ID: 34132623
[TBL] [Abstract][Full Text] [Related]
5. Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011-2015 Comparison Using Real-World Data.
Mucherino S; Gimeno-Miguel A; Carmona-Pirez J; Gonzalez-Rubio F; Ioakeim-Skoufa I; Moreno-Juste A; Orlando V; Aza-Pascual-Salcedo M; Poblador-Plou B; Menditto E; Prados-Torres A
Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33919351
[TBL] [Abstract][Full Text] [Related]
6. Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients.
Guisado-Clavero M; Violán C; López-Jimenez T; Roso-Llorach A; Pons-Vigués M; Muñoz MA; Foguet-Boreu Q
BMC Fam Pract; 2019 Jun; 20(1):82. PubMed ID: 31195985
[TBL] [Abstract][Full Text] [Related]
7. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
[TBL] [Abstract][Full Text] [Related]
8. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).
Prados-Torres A; Del Cura-González I; Prados-Torres D; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; López-Verde F; Gimeno-Feliu LA; Escortell-Mayor E; Pico-Soler V; Sanz-Cuesta T; Bujalance-Zafra MJ; Morey-Montalvo M; Boxó-Cifuentes JR; Poblador-Plou B; Fernández-Arquero JM; González-Rubio F; Ramiro-González MD; Coscollar-Santaliestra C; Martín-Fernández J; Barnestein-Fonseca MP; Valderas-Martínez JM; Marengoni A; Muth C;
Implement Sci; 2017 Apr; 12(1):54. PubMed ID: 28449721
[TBL] [Abstract][Full Text] [Related]
10. Managing multimorbidity in primary care in patients with chronic respiratory conditions.
Morrison D; Agur K; Mercer S; Eiras A; González-Montalvo JI; Gruffydd-Jones K
NPJ Prim Care Respir Med; 2016 Sep; 26():16043. PubMed ID: 27629064
[TBL] [Abstract][Full Text] [Related]
11. Improving individualized prescription in patients with multimorbidity through medication review.
Molist-Brunet N; Sevilla-Sánchez D; Puigoriol-Juvanteny E; Barneto-Soto M; González-Bueno J; Espaulella-Panicot J
BMC Geriatr; 2022 May; 22(1):417. PubMed ID: 35549672
[TBL] [Abstract][Full Text] [Related]
12. Multimorbidity Clusters in the Oldest Old: Results from the EpiChron Cohort.
Ioakeim-Skoufa I; Clerencia-Sierra M; Moreno-Juste A; Elías de Molins Peña C; Poblador-Plou B; Aza-Pascual-Salcedo M; González-Rubio F; Prados-Torres A; Gimeno-Miguel A
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011814
[TBL] [Abstract][Full Text] [Related]
13. Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study.
Holvast F; van Hattem BA; Sinnige J; Schellevis F; Taxis K; Burger H; Verhaak PFM
Fam Pract; 2017 Sep; 34(5):539-545. PubMed ID: 28369380
[TBL] [Abstract][Full Text] [Related]
14. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
[TBL] [Abstract][Full Text] [Related]
15. Primary care utilisation, adherence to guideline-based pharmacotherapy and continuity of care in primary care patients with chronic diseases and multimorbidity - a cross-sectional study.
Maun A; Björkelund C; Arvidsson E
BMC Prim Care; 2023 Nov; 24(1):237. PubMed ID: 37957554
[TBL] [Abstract][Full Text] [Related]
16. Multimorbidity in Māori and Pacific patients: cross-sectional study in a Dunedin general practice.
Stokes T; Azam M; Noble FD
J Prim Health Care; 2018 Mar; 10(1):39-43. PubMed ID: 30068450
[TBL] [Abstract][Full Text] [Related]
17. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden.
Gallacher KI; Batty GD; McLean G; Mercer SW; Guthrie B; May CR; Langhorne P; Mair FS
BMC Med; 2014 Oct; 12():151. PubMed ID: 25280748
[TBL] [Abstract][Full Text] [Related]
18. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
[TBL] [Abstract][Full Text] [Related]
19. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population.
Aoki T; Yamamoto Y; Ikenoue T; Onishi Y; Fukuhara S
Sci Rep; 2018 Feb; 8(1):3806. PubMed ID: 29491441
[TBL] [Abstract][Full Text] [Related]
20. The association of parity number with multimorbidity and polypharmacy among Iranian women in the Azarcohort: a cross-sectional study.
Faramarzi E; Somi MH; Tutunchi H; Almaspour H; Sanaie S; Asemani S
BMC Womens Health; 2023 Jun; 23(1):295. PubMed ID: 37264361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
